The University of Southampton
University of Southampton Institutional Repository

Ketone monoester ingestion improves cardiac function in adults with type 2 diabetes: a double-blind, placebo controlled, randomised, crossover trial

Ketone monoester ingestion improves cardiac function in adults with type 2 diabetes: a double-blind, placebo controlled, randomised, crossover trial
Ketone monoester ingestion improves cardiac function in adults with type 2 diabetes: a double-blind, placebo controlled, randomised, crossover trial
Type 2 diabetes (T2D) is a metabolic disease associated with cardiovascular dysfunction. The myocardium preferentially uses ketones over free fatty acids as a more energy efficient substrate. The primary aim was to assess the effects of ketone monoester (Kme) ingestion on cardiac output index (Q̇i). Secondary aims were to assess the effects of Kme ingestion on markers of cardiac haemodynamics, muscle oxygenation and vascular function at rest, during and following step-incremental cycling.

We undertook a double-blind, randomised, crossover design study in 13 adults (age, 66±10 y; BMI, 31.3±7.0 kg·m−2) with T2D. Participants completed two conditions, where they ingested a Kme (0.115 g‧kg−1) or a placebo taste-mathced drink. Cardiac function was measured using thoracic impedance cardiography and muscle oxygenation of the calf was determined via near-infrared spectroscopy. Macrovascular endothelial function was measured by flow mediated dilation (FMD) and microvascular endothelial function was measured via transdermal delivery of acetylcholine (ACh) and insulin. Circulating β-hydroxybutyrate [β-Hb] was measured throughout.

Kme ingestion raised circulating β-Hb throughout the protocol (peak 1.9 mM; P=0.001 vs. placebo). Kme ingestion increased Q̇i by 0.75±0.5 L∙min−1∙m−2 (P=0.003) stroke volume index by 7.2±4.5 mL∙m−2 (P=0.001), and peripheral muscle oxygenation by 9.9±7.1% (P=0.001) and reduced systemic vascular resistance index by-420±-225 dyn∙s−1∙cm−5∙m−2 (P=0.031) compared to placebo condition. There were no differences between Kme and placebo in heart rate (P=0.995), FMD (P=0.542), ACh max (P=0.800), insulin max (P=0.242).

Ingestion of Kme improved Q̇i, stroke volume index and peripheral muscle oxygenation, but did not alter macro- or microvascular endothelial function in people with T2D.

cardiovascular hemodynamics, diabetes, exercise, muscle oxygenation, β-hydroxybutyrate
8750-7587
546-558
M., Perissiou
9bab724f-3bf8-43d9-a568-343dabc145cd
Saynor, Z.L.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
Feka, K.
e416f7e1-7687-4d7c-b181-fe9d30ce6d39
James, T.J.
ec4847bb-15f8-45ef-9e77-66debeb8ed14
Corbett, J.
a37f2421-d68b-4ddd-b3db-28984905e6f6
Mayes, H.
ab07a6bb-f421-4997-bff6-7dd6ee9ae1e9
Shute, J.
d34e3fea-c758-47b5-a4ef-2ec0ed499e0d
Cummings, M.
6a6f653e-f9b5-4d68-a6c3-dd67f1331d2e
Black, M.I.
09236f71-70b1-4d3a-93c2-8630dccfd90b
Strain, W.D.
396d8684-8e45-4e87-8cfd-26ba12759aba
Little, J.P.
055fac0d-1bdf-44ed-98ba-0f1ed86bfc6c
Shepherd, A.I.
dbabc753-64ee-4397-8af6-7c7403356460
M., Perissiou
9bab724f-3bf8-43d9-a568-343dabc145cd
Saynor, Z.L.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
Feka, K.
e416f7e1-7687-4d7c-b181-fe9d30ce6d39
James, T.J.
ec4847bb-15f8-45ef-9e77-66debeb8ed14
Corbett, J.
a37f2421-d68b-4ddd-b3db-28984905e6f6
Mayes, H.
ab07a6bb-f421-4997-bff6-7dd6ee9ae1e9
Shute, J.
d34e3fea-c758-47b5-a4ef-2ec0ed499e0d
Cummings, M.
6a6f653e-f9b5-4d68-a6c3-dd67f1331d2e
Black, M.I.
09236f71-70b1-4d3a-93c2-8630dccfd90b
Strain, W.D.
396d8684-8e45-4e87-8cfd-26ba12759aba
Little, J.P.
055fac0d-1bdf-44ed-98ba-0f1ed86bfc6c
Shepherd, A.I.
dbabc753-64ee-4397-8af6-7c7403356460

M., Perissiou, Saynor, Z.L., Feka, K., James, T.J., Corbett, J., Mayes, H., Shute, J., Cummings, M., Black, M.I., Strain, W.D., Little, J.P. and Shepherd, A.I. (2025) Ketone monoester ingestion improves cardiac function in adults with type 2 diabetes: a double-blind, placebo controlled, randomised, crossover trial. Journal of Applied Physiology, 138 (2), 546-558. (doi:10.1152/japplphysiol.00800.2024).

Record type: Article

Abstract

Type 2 diabetes (T2D) is a metabolic disease associated with cardiovascular dysfunction. The myocardium preferentially uses ketones over free fatty acids as a more energy efficient substrate. The primary aim was to assess the effects of ketone monoester (Kme) ingestion on cardiac output index (Q̇i). Secondary aims were to assess the effects of Kme ingestion on markers of cardiac haemodynamics, muscle oxygenation and vascular function at rest, during and following step-incremental cycling.

We undertook a double-blind, randomised, crossover design study in 13 adults (age, 66±10 y; BMI, 31.3±7.0 kg·m−2) with T2D. Participants completed two conditions, where they ingested a Kme (0.115 g‧kg−1) or a placebo taste-mathced drink. Cardiac function was measured using thoracic impedance cardiography and muscle oxygenation of the calf was determined via near-infrared spectroscopy. Macrovascular endothelial function was measured by flow mediated dilation (FMD) and microvascular endothelial function was measured via transdermal delivery of acetylcholine (ACh) and insulin. Circulating β-hydroxybutyrate [β-Hb] was measured throughout.

Kme ingestion raised circulating β-Hb throughout the protocol (peak 1.9 mM; P=0.001 vs. placebo). Kme ingestion increased Q̇i by 0.75±0.5 L∙min−1∙m−2 (P=0.003) stroke volume index by 7.2±4.5 mL∙m−2 (P=0.001), and peripheral muscle oxygenation by 9.9±7.1% (P=0.001) and reduced systemic vascular resistance index by-420±-225 dyn∙s−1∙cm−5∙m−2 (P=0.031) compared to placebo condition. There were no differences between Kme and placebo in heart rate (P=0.995), FMD (P=0.542), ACh max (P=0.800), insulin max (P=0.242).

Ingestion of Kme improved Q̇i, stroke volume index and peripheral muscle oxygenation, but did not alter macro- or microvascular endothelial function in people with T2D.

Text
KE_in_T2DM_JAP_Mendeley_JAPPL_revised_clean - Accepted Manuscript
Restricted to Repository staff only until 17 January 2026.
Request a copy

More information

Accepted/In Press date: 9 January 2025
e-pub ahead of print date: 17 January 2025
Published date: 1 February 2025
Keywords: cardiovascular hemodynamics, diabetes, exercise, muscle oxygenation, β-hydroxybutyrate

Identifiers

Local EPrints ID: 498121
URI: http://eprints.soton.ac.uk/id/eprint/498121
ISSN: 8750-7587
PURE UUID: b817b333-c660-4741-bf7d-b2ecb41b73df
ORCID for Z.L. Saynor: ORCID iD orcid.org/0000-0003-0674-8477

Catalogue record

Date deposited: 10 Feb 2025 17:52
Last modified: 03 Sep 2025 02:12

Export record

Altmetrics

Contributors

Author: Perissiou M.
Author: Z.L. Saynor ORCID iD
Author: K. Feka
Author: T.J. James
Author: J. Corbett
Author: H. Mayes
Author: J. Shute
Author: M. Cummings
Author: M.I. Black
Author: W.D. Strain
Author: J.P. Little
Author: A.I. Shepherd

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×